- IBDEI3C0 ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.4,2465,0)
- ;;=ESTABLISHED PATIENT ^1^190
- ;;^UTILITY(U,$J,358.4,2466,0)
- ;;=CONSULTATIONS ^3^190
- ;;^UTILITY(U,$J,358.4,2467,0)
- ;;=NEOPLASMS^9^191
- ;;^UTILITY(U,$J,358.4,2468,0)
- ;;=CARDIOVASCULAR DISORDERS^2^191
- ;;^UTILITY(U,$J,358.4,2469,0)
- ;;=MENTAL HEALTH^8^191
- ;;^UTILITY(U,$J,358.4,2470,0)
- ;;=NEUROLOGICAL CONDITIONS^10^191
- ;;^UTILITY(U,$J,358.4,2471,0)
- ;;=GI DISORDERS^5^191
- ;;^UTILITY(U,$J,358.4,2472,0)
- ;;=LIVER DISORDERS^7^191
- ;;^UTILITY(U,$J,358.4,2473,0)
- ;;=KIDNEY DISORDERS^6^191
- ;;^UTILITY(U,$J,358.4,2474,0)
- ;;=RESPIRATORY DISORDERS^11^191
- ;;^UTILITY(U,$J,358.4,2475,0)
- ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^191
- ;;^UTILITY(U,$J,358.4,2476,0)
- ;;=OTHER CONDITIONS^13^191
- ;;^UTILITY(U,$J,358.4,2477,0)
- ;;=DEMENTIA^3^191
- ;;^UTILITY(U,$J,358.4,2478,0)
- ;;=GENERAL IM^4^191
- ;;^UTILITY(U,$J,358.4,2479,0)
- ;;=OTHER BACTERIAL DISEASES^12^191
- ;;^UTILITY(U,$J,358.4,2480,0)
- ;;=HEALTH/BEHAVIOR ASSESSMENT^1^192
- ;;^UTILITY(U,$J,358.4,2481,0)
- ;;=HEALTH/BEHAVIOR INTERVENTION^2^192
- ;;^UTILITY(U,$J,358.4,2482,0)
- ;;=PC COMMON DIAGNOSES^1^193
- ;;^UTILITY(U,$J,358.4,2483,0)
- ;;=ADMINISTRATIVE TOPICS^15^193
- ;;^UTILITY(U,$J,358.4,2484,0)
- ;;=ANGINA^16^193
- ;;^UTILITY(U,$J,358.4,2485,0)
- ;;=ATHEROSCLEROSIS^17^193
- ;;^UTILITY(U,$J,358.4,2486,0)
- ;;=CARDIOVASCULAR^18^193
- ;;^UTILITY(U,$J,358.4,2487,0)
- ;;=DERMATOLOGY^22^193
- ;;^UTILITY(U,$J,358.4,2488,0)
- ;;=EAR DISORDERS^24^193
- ;;^UTILITY(U,$J,358.4,2489,0)
- ;;=EENT^25^193
- ;;^UTILITY(U,$J,358.4,2490,0)
- ;;=ENDOCRINE/METABOLIC^26^193
- ;;^UTILITY(U,$J,358.4,2491,0)
- ;;=EYE DISORDERS^27^193
- ;;^UTILITY(U,$J,358.4,2492,0)
- ;;=EYE INJURY^28^193
- ;;^UTILITY(U,$J,358.4,2493,0)
- ;;=GASTROENTEROLOGY^29^193
- ;;^UTILITY(U,$J,358.4,2494,0)
- ;;=GU/RENAL^30^193
- ;;^UTILITY(U,$J,358.4,2495,0)
- ;;=HEADACHE^31^193
- ;;^UTILITY(U,$J,358.4,2496,0)
- ;;=HEART VALVE DISEASE^32^193
- ;;^UTILITY(U,$J,358.4,2497,0)
- ;;=HEMATOLOGY/ONCOLOGY^33^193
- ;;^UTILITY(U,$J,358.4,2498,0)
- ;;=HISTORY OF ILLNESS^34^193
- ;;^UTILITY(U,$J,358.4,2499,0)
- ;;=INFECTIOUS DISEASE^35^193
- ;;^UTILITY(U,$J,358.4,2500,0)
- ;;=LIVER DISEASE^36^193
- ;;^UTILITY(U,$J,358.4,2501,0)
- ;;=MENTAL HEALTH^38^193
- ;;^UTILITY(U,$J,358.4,2502,0)
- ;;=MOVEMENT DISORDERS^39^193
- ;;^UTILITY(U,$J,358.4,2503,0)
- ;;=MUSCULOSKELETAL^40^193
- ;;^UTILITY(U,$J,358.4,2504,0)
- ;;=NEUROLOGY^41^193
- ;;^UTILITY(U,$J,358.4,2505,0)
- ;;=PAIN^42^193
- ;;^UTILITY(U,$J,358.4,2506,0)
- ;;=PREVENTIVE HEALTH^43^193
- ;;^UTILITY(U,$J,358.4,2507,0)
- ;;=PULMONARY^44^193
- ;;^UTILITY(U,$J,358.4,2508,0)
- ;;=SEXUAL TRAUMA^45^193
- ;;^UTILITY(U,$J,358.4,2509,0)
- ;;=SIGNS,SYMPTOMS,CONDITIONS^46^193
- ;;^UTILITY(U,$J,358.4,2510,0)
- ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^193
- ;;^UTILITY(U,$J,358.4,2511,0)
- ;;=SUBSTANCE DISORDERS^48^193
- ;;^UTILITY(U,$J,358.4,2512,0)
- ;;=VARICOSE VEINS^50^193
- ;;^UTILITY(U,$J,358.4,2513,0)
- ;;=WOMEN'S HEALTH^51^193
- ;;^UTILITY(U,$J,358.4,2514,0)
- ;;=WOUNDS-INITIAL ENCOUNTER^52^193
- ;;^UTILITY(U,$J,358.4,2515,0)
- ;;=COMA^20^193
- ;;^UTILITY(U,$J,358.4,2516,0)
- ;;=CAUSES OF INJURY^19^193
- ;;^UTILITY(U,$J,358.4,2517,0)
- ;;=DEMENTIA^21^193
- ;;^UTILITY(U,$J,358.4,2518,0)
- ;;=LONG TERM CURRENT DRUG THERAPY^37^193
- ;;^UTILITY(U,$J,358.4,2519,0)
- ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^193
- ;;^UTILITY(U,$J,358.4,2520,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^49^193
- ;;^UTILITY(U,$J,358.4,2521,0)
- ;;=ACSC ACUTE KIDNEY FAILURE^3^193
- ;;^UTILITY(U,$J,358.4,2522,0)
- ;;=ACSC ANGINA^4^193
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3C0 3797 printed Feb 19, 2025@00:12:15 Page 2
- IBDEI3C0 ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.4)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.4,2465,0)
- +2 ;;=ESTABLISHED PATIENT ^1^190
- +3 ;;^UTILITY(U,$J,358.4,2466,0)
- +4 ;;=CONSULTATIONS ^3^190
- +5 ;;^UTILITY(U,$J,358.4,2467,0)
- +6 ;;=NEOPLASMS^9^191
- +7 ;;^UTILITY(U,$J,358.4,2468,0)
- +8 ;;=CARDIOVASCULAR DISORDERS^2^191
- +9 ;;^UTILITY(U,$J,358.4,2469,0)
- +10 ;;=MENTAL HEALTH^8^191
- +11 ;;^UTILITY(U,$J,358.4,2470,0)
- +12 ;;=NEUROLOGICAL CONDITIONS^10^191
- +13 ;;^UTILITY(U,$J,358.4,2471,0)
- +14 ;;=GI DISORDERS^5^191
- +15 ;;^UTILITY(U,$J,358.4,2472,0)
- +16 ;;=LIVER DISORDERS^7^191
- +17 ;;^UTILITY(U,$J,358.4,2473,0)
- +18 ;;=KIDNEY DISORDERS^6^191
- +19 ;;^UTILITY(U,$J,358.4,2474,0)
- +20 ;;=RESPIRATORY DISORDERS^11^191
- +21 ;;^UTILITY(U,$J,358.4,2475,0)
- +22 ;;=PALLIATIVE/HOSPICE ENCOUNTER^1^191
- +23 ;;^UTILITY(U,$J,358.4,2476,0)
- +24 ;;=OTHER CONDITIONS^13^191
- +25 ;;^UTILITY(U,$J,358.4,2477,0)
- +26 ;;=DEMENTIA^3^191
- +27 ;;^UTILITY(U,$J,358.4,2478,0)
- +28 ;;=GENERAL IM^4^191
- +29 ;;^UTILITY(U,$J,358.4,2479,0)
- +30 ;;=OTHER BACTERIAL DISEASES^12^191
- +31 ;;^UTILITY(U,$J,358.4,2480,0)
- +32 ;;=HEALTH/BEHAVIOR ASSESSMENT^1^192
- +33 ;;^UTILITY(U,$J,358.4,2481,0)
- +34 ;;=HEALTH/BEHAVIOR INTERVENTION^2^192
- +35 ;;^UTILITY(U,$J,358.4,2482,0)
- +36 ;;=PC COMMON DIAGNOSES^1^193
- +37 ;;^UTILITY(U,$J,358.4,2483,0)
- +38 ;;=ADMINISTRATIVE TOPICS^15^193
- +39 ;;^UTILITY(U,$J,358.4,2484,0)
- +40 ;;=ANGINA^16^193
- +41 ;;^UTILITY(U,$J,358.4,2485,0)
- +42 ;;=ATHEROSCLEROSIS^17^193
- +43 ;;^UTILITY(U,$J,358.4,2486,0)
- +44 ;;=CARDIOVASCULAR^18^193
- +45 ;;^UTILITY(U,$J,358.4,2487,0)
- +46 ;;=DERMATOLOGY^22^193
- +47 ;;^UTILITY(U,$J,358.4,2488,0)
- +48 ;;=EAR DISORDERS^24^193
- +49 ;;^UTILITY(U,$J,358.4,2489,0)
- +50 ;;=EENT^25^193
- +51 ;;^UTILITY(U,$J,358.4,2490,0)
- +52 ;;=ENDOCRINE/METABOLIC^26^193
- +53 ;;^UTILITY(U,$J,358.4,2491,0)
- +54 ;;=EYE DISORDERS^27^193
- +55 ;;^UTILITY(U,$J,358.4,2492,0)
- +56 ;;=EYE INJURY^28^193
- +57 ;;^UTILITY(U,$J,358.4,2493,0)
- +58 ;;=GASTROENTEROLOGY^29^193
- +59 ;;^UTILITY(U,$J,358.4,2494,0)
- +60 ;;=GU/RENAL^30^193
- +61 ;;^UTILITY(U,$J,358.4,2495,0)
- +62 ;;=HEADACHE^31^193
- +63 ;;^UTILITY(U,$J,358.4,2496,0)
- +64 ;;=HEART VALVE DISEASE^32^193
- +65 ;;^UTILITY(U,$J,358.4,2497,0)
- +66 ;;=HEMATOLOGY/ONCOLOGY^33^193
- +67 ;;^UTILITY(U,$J,358.4,2498,0)
- +68 ;;=HISTORY OF ILLNESS^34^193
- +69 ;;^UTILITY(U,$J,358.4,2499,0)
- +70 ;;=INFECTIOUS DISEASE^35^193
- +71 ;;^UTILITY(U,$J,358.4,2500,0)
- +72 ;;=LIVER DISEASE^36^193
- +73 ;;^UTILITY(U,$J,358.4,2501,0)
- +74 ;;=MENTAL HEALTH^38^193
- +75 ;;^UTILITY(U,$J,358.4,2502,0)
- +76 ;;=MOVEMENT DISORDERS^39^193
- +77 ;;^UTILITY(U,$J,358.4,2503,0)
- +78 ;;=MUSCULOSKELETAL^40^193
- +79 ;;^UTILITY(U,$J,358.4,2504,0)
- +80 ;;=NEUROLOGY^41^193
- +81 ;;^UTILITY(U,$J,358.4,2505,0)
- +82 ;;=PAIN^42^193
- +83 ;;^UTILITY(U,$J,358.4,2506,0)
- +84 ;;=PREVENTIVE HEALTH^43^193
- +85 ;;^UTILITY(U,$J,358.4,2507,0)
- +86 ;;=PULMONARY^44^193
- +87 ;;^UTILITY(U,$J,358.4,2508,0)
- +88 ;;=SEXUAL TRAUMA^45^193
- +89 ;;^UTILITY(U,$J,358.4,2509,0)
- +90 ;;=SIGNS,SYMPTOMS,CONDITIONS^46^193
- +91 ;;^UTILITY(U,$J,358.4,2510,0)
- +92 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^193
- +93 ;;^UTILITY(U,$J,358.4,2511,0)
- +94 ;;=SUBSTANCE DISORDERS^48^193
- +95 ;;^UTILITY(U,$J,358.4,2512,0)
- +96 ;;=VARICOSE VEINS^50^193
- +97 ;;^UTILITY(U,$J,358.4,2513,0)
- +98 ;;=WOMEN'S HEALTH^51^193
- +99 ;;^UTILITY(U,$J,358.4,2514,0)
- +100 ;;=WOUNDS-INITIAL ENCOUNTER^52^193
- +101 ;;^UTILITY(U,$J,358.4,2515,0)
- +102 ;;=COMA^20^193
- +103 ;;^UTILITY(U,$J,358.4,2516,0)
- +104 ;;=CAUSES OF INJURY^19^193
- +105 ;;^UTILITY(U,$J,358.4,2517,0)
- +106 ;;=DEMENTIA^21^193
- +107 ;;^UTILITY(U,$J,358.4,2518,0)
- +108 ;;=LONG TERM CURRENT DRUG THERAPY^37^193
- +109 ;;^UTILITY(U,$J,358.4,2519,0)
- +110 ;;=ACQUIRED ABSENCE OF BODY PART(S)^2^193
- +111 ;;^UTILITY(U,$J,358.4,2520,0)
- +112 ;;=SUICIDE IDEATIONS/ATTEMPTS^49^193
- +113 ;;^UTILITY(U,$J,358.4,2521,0)
- +114 ;;=ACSC ACUTE KIDNEY FAILURE^3^193
- +115 ;;^UTILITY(U,$J,358.4,2522,0)
- +116 ;;=ACSC ANGINA^4^193
